Complicated Pneumonia (CP) in Children in South-East Europe

Recruiting Observational Study
Pneumonia, Necrotizing Lung Abscess Empyema, Pleural
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
1 Month – 18
Sex
Any
Study type
Observational
Participants needed
300 (estimated)
Sponsor
Aleksandar Sovtic · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
This retrospective observational study aims to evaluate clinical course of complicated community acquired pneumonia in children, particularly focusing on necrotizing pneumonia cases, as well as determination of etiological agents (viruses and bacteria) and its association to severity and outcomes of the disease. Furthermore, therapeutic approach, complications, short-term and long-term outcomes an…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria * Children aged 1 month to 18 years of age * Children diagnosed with complicated community acquired pneumonia (pneumonia with parapneumonic effusion, necrotizing pneumonia and lung abscess) * Children who were hospitalized from January 1st 2014 to April 30th 2024 and required at …
Contacts

Aleksandar Sovtic, M.D. Ph.D

+381113108158

aleksandar.sovtic@imd.org.rs

CONTACT

Tijana Grba, M.D.

+381113108158

tijana.grba@imd.org.rs

CONTACT